Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Opthea Limited ( (AU:OPT) ) is now available.
Opthea Limited has announced the application for the quotation of 1,221 new ordinary fully paid securities on the Australian Securities Exchange, effective February 10, 2025. This move may enhance Opthea’s market position by potentially increasing its visibility and access to capital, which could have implications for its stakeholders.
More about Opthea Limited
Opthea Limited operates within the biotechnology industry, focusing on developing therapies for eye diseases.
YTD Price Performance: 9.09%
Average Trading Volume: 9,900
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $868.9M
For detailed information about OPT stock, go to TipRanks’ Stock Analysis page.
